Table 3 Univariable and multivariable logistic regression model for the heightened regret in patients undergoing thyroidectomy

From: A multicenter cohort study of thyroidectomy-related decision regret in patients with low-risk papillary thyroid microcarcinoma

Characteristics

Univariable analysis

Multivariable analysis

Heightened regret (N = 319)

No or mild regret (N = 997)

P value

Odds ratio

95% CI

P value

Age, mean (SD), years

43.9 (9.9)

43.3 (10.2)

0.392

   

Patient gender

  

0.264

   

 Female

241 (75.5)

783 (78.5)

    

 Male

78 (24.5)

214 (21.5)

    

Patient race/ethnicity

  

0.589

   

 Han

311 (97.5)

977 (98.0)

    

 Others

8 (2.5)

20 (2.0)

    

Tumor size, mean (SD), mm

7.1 (2.1)

7.0 (1.8)

0.858

   

Marital status

  

0.156

   

 Married/living as married

278 (87.1)

897 (90.0)

    

 Others

41 (12.9)

100 (10.0)

    

Current employment status

  

<0.001

1.343

0.688–2.612

0.387

 Employed

302 (94.7)

840 (84.3)

    

 Others

17 (5.3)

157 (15.7)

    

Comorbidities of thyroid

      

 Nodular goiter

165 (51.7)

344 (34.5)

<0.001

1.193

0.739–1.926

0.470

 Hashimoto’s thyroiditis

56 (17.6)

99 (9.9)

0.004

1.094

0.852–2.809

0.515

Other comorbidities

 0

253 (79.3)

808 (81.0)

0.496

   

 1

43 (13.5)

131 (13.2)

    

 ≥2

23 (7.2)

58 (5.8)

    

Extent of thyroidectomy

  

0.180

   

 Total thyroidectomy

116 (36.4)

322 (32.3)

    

 Lobectomy

203 (63.6)

675 (67.7)

    

Central lymph node dissection

  

<0.001

0.599

0.278–1.292

0.191

 Unilateral

207 (64.9)

762 (76.4)

    

 Bilateral

112 (35.1)

235 (23.6)

    

Thyroid hormone replacement/ suppression therapy

  

0.299

   

 Yes

280 (87.8)

852 (85.5)

    

 No

39 (12.2)

145 (14.5)

    

TSH, mean (SD), (mIU/L)

1.2 (1.1)

1.3 (1.4)

0.220

   

FT3, mean (SD), (pmol/L)

4.7 (1.8)

4.7 (1.5)

0.921

   

FT4, mean (SD), (pmol/L)

18.8 (3.2)

19.0 (3.2)

0.498

   

Postoperative complications

12 (3.8)

0 (0.0)

<0.001

3.116

1.531–10.782

0.016

Postoperative pathological features

 Gross or microscopic ETE

0 (0.0)

85 (8.5)

<0.001

0.612

0.222–1.076

0.088

 Lymph node metastasis

0 (0.0)

399 (40.0)

<0.001

0.347

0.104–0.864

<0.001

Median time from operation to distribution of survey (months)

35 (6–73)

34 (6–74)

0.869

   

Disease progression

7 (2.2)

11 (1.1)

0.144

   

Decision-making experiences

 Completely patient’s choice

37 (11.6)

151 (15.1)

0.115

   

 Primarily based on my doctor’s recommendation

107 (33.5)

298 (29.9)

0.219

   

 Doctor and patient made decision together

166 (52.0)

542 (54.4)

0.468

   

 Someone else’s choice

9 (2.9)

6 (0.6)

0.001

5.086

0.839–30.845

0.077

Understanding of disease

 Not at all

114 (35.7)

106 (10.6)

<0.001

4.216

2.357–9.996

<0.001

 A little

73 (22.9)

176 (17.7)

0.038

   

 Quite a bit

60 (18.8)

441 (44.2)

<0.001

0.752

0.314–1.422

0.110

 Very much

72 (22.6)

274 (27.5)

0.083

   

Communication quality

 High

289 (90.6)

973 (97.6)

<0.001

0.451

0.232–0.917

0.002

 Low

30 (9.4)

24 (2.4)

    

Thyroid cancer-specific QoL

 Neuromuscular (high/low)

148 (46.4)/171 (53.6)

311 (31.2)/686 (68.8)

<0.001

1.231

0.720–2.104

0.448

 Voice (high/low)

150 (47.0)/169 (53.0)

369 (37.0)/628 (63.0)

0.002

0.992

0.611–1.610

0.974

 Concentration (high/low)

162 (50.8)/157 (49.2)

334 (33.5)/663 (66.5)

<0.001

1.593

0.918–2.766

0.098

 Sympathetic (high/low)

122 (38.2)/197 (61.8)

276 (27.7)/721 (72.3)

<0.001

1.281

0.766–2.141

0.346

 Throat/mouth (high/low)

145 (45.5)/174(54.5)

310 (33.1)/687 (68.9)

<0.001

0.903

0.542–1.506

0.697

 Psychological (high/low)

187 (58.6)/132 (41.4)

464 (46.5)/533 (53.5)

<0.001

1.835

1.248–2.988

0.039

 Sensory (high/low)

152 (47.6)/167 (52.4)

407 (40.8)/590 (59.2)

0.032

1.073

0.567–1.753

0.778

 Scarring (high/low)

213 (66.8)/106 (33.2)

445 (44.6)/552 (55.4)

<0.001

2.907

1.527–3.920

0.021

 Chilly (high/low)

174 (54.5)/145 (45.5)

447 (44.8)/550 (55.2)

0.003

0.996

0.590–1.582

0.892

 Tingling (high/low)

149 (46.7)/170 (53.3)

300 (30.1)/697 (69.9)

<0.001

1.488

0.872–2.539

0.145

 Weight gain (high/low)

48 (15.0)/271 (85.0)

134 (13.4)/863 (86.6)

0.469

   

 Headache (high/low)

155 (48.6)/164 (51.4)

376 (37.7)/621 (62.3)

<0.001

0.996

0.599–1.658

0.898

 Sex (high/low)

57 (17.9)/262 (82.1)

99 (9.9)/898 (90.1)

<0.001

1.984

0.917–3.607

0.077

  1. Logistic regression was used to evaluate factors associated with heightened regret. Statistical significance was assessed at a two-sided level.
  2. ETE extrathyroidal extension, FT3 free T3, FT4 free T4, QoL quality of life, SD standard deviation, TSH thyroid stimulating hormone.